Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
This study has been terminated.
( Terminated due to slow accrual. )
Study NCT00897806
Information provided by M.D. Anderson Cancer Center
First Received on May 9, 2009.
Last Updated on July 27, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
